vWf levels as a circulating marker of endothelial dysfunction in patients with hypertrophic cardiomyopathy

Indian Heart Journal

Volumn 57, Issue 6, 2005, Pages 655-657

  Varol, Ercan ^a,b   Ozaydin, Mehmet ^a   Sahin, Mehmet ^a   Altinbas, Ahmet ^a   Kosar, Feridun ^a  

^a SULEYMAN DEMIREL UNIVERSITY   (Turkey)

^b Anadolu Mah ESO (Memur) Evleri C   (Turkey)

Author keywords

Endothelial dysfunction; Hypertrophic cardiomyopathy; von Willebrand factor

Indexed keywords

BIOLOGICAL MARKER; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; ENDOTHELIAL DYSFUNCTION; FEMALE; HEALTH STATUS; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; PROTEIN BLOOD LEVEL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADULT; AGED; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CARDIOMYOPATHY, DILATED; CASE-CONTROL STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; PROBABILITY; PROGNOSIS; PROSPECTIVE STUDIES; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; VON WILLEBRAND FACTOR;

EID: 33644679099     PISSN: 00194832     EISSN: 00194832     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Lip GY, Blann A. von Willebrand factor: a marker of endothelial dysfunction in vascular disorders? Cardiovasc Res 1997; 34: 255-265
2. Blann AD. von Willebrand factor and the endothelium in vascular disease. Br J Biomed Sci 1993; 50: 125-134
3. Blann AD, Taberner DA. A reliable marker of endothelial cell dysfunction: does it exist? Br J Haematol 1995; 90: 244-248
4. Pearson JD. Markers of endothelial cell perturbation and damage. Br J Rheumatol 1993; 32: 651-652
5. Lip GY, Foster W, Blann AD. Plasma von Willebrand factor levels and surrogates of atherosclerosis. J Thromb Haemost 2005; 3: 659-661
6. Dimitrow PP. Coronary vasospasm in hypertrophic cardiomyopathy. Chest 2001; 119: 1289-1291
7. Iida H, Fujii T, Miura T. Assessment of endothelium dependent coronary vasodilatation in hypertrophic cardiomyopathy [Abstr]. Circulation 1996; 94: 1502
8. Dimitrow PP, Krzanowski M, Nizankowski R, Szczeklik A, Dubiel JS. Verapamil improves the response of coronary vasomotion to cold pressor test in asymptomatic and mildly symptomatic patients with hypertrophic cardiomyopathy. Cardiovasc Drugs Ther 1999; 13: 259-264
9. Maron BJ, Bonow RO, Cannon RO 3rd, Leon MB, Epstein SE. Hypertrophic cardiomyopathy: interrelations of clinical manifestations, pathophysiology and therapy. N Engl J Med 1987; 316: 780-789
10. Lip GY, Lowe GD, Metcalfe MJ, Rumley A, Dunn FG. Effects of warfarin therapy on plasma fibrinogen, von Willebrand factor, and fibrin D-dimer in left ventricular dysfunction secondary to coronary artery disease with and without aneurysms. Am J Cardiol 1995; 76: 453-458
11. Gibbs CR, Blann AD, Watson RD, Lip GY. Abnormalities of hemorheological, endothelial, and platelet function in patients with chronic heart failure in sinus rhythm: effects of angiotensin-converting enzyme inhibitor and beta-blocker therapy. Circulation 2001; 103: 1746-1751
12. Zarifis J. Diastolic dysfunction: a review. Eur J Intern Med 1995; 6: 145-154
13. Lip GY, Lowe GD, Metcalfe MJ, Rumley A, Dunn FG. Is diastolic dysfunction associated with thrombogenesis? A study of circulating markers of a prothrombotic state in patients with coronary artery disease. Int J Cardiol 1995; 50: 31-42
14. Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction. A marker of atherosclerosis risk. Arterioscler Thromb Vasc Biol 2003; 23: 168-175
15. Ruggeri ZM, Ware J. The structure and function of von Willebrand factor. Thromb Haemost 1992; 67: 594-599
16. Conway DS, Pearce LA, Chin BS, Hart RG, Lip GY. Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation. Circulation 2003; 107: 3141-3145
17. Lee KW, Lip GY, Tayebjee M, Foster W, Blann AD. Circulating endothelial cells, Willebrand von factor, interleukin-6, and prognosis in patients with acute coronary syndromes. Blood 2005; 105: 526-532
18. Kubo SH, Rector TS, Bank AJ, Williams RE, Heifetz SM. Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circulation 1991; 84: 1589-1596
19. Lip GY, Blann AD. von Willebrand factor and its relevance to cardiovascular disorders. Br Heart J 1995; 74: 580-583
20. Yokohoma H, Matsumoto T, Horie H, Minai K, Kinoshita M. Coronary endothelium-dependent and independent vasomotor responses in patients with hypertrophic cardiomyopathy. Circ J 2002; 66: 30-34